Aclarion (ACONW) Competitors $0.02 0.00 (-7.06%) As of 09:58 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock ACONW vs. AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, VSEE, and NTRAShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), VSee Health (VSEE), and Natera (NTRA). These companies are all part of the "healthcare" industry. Aclarion vs. Its Competitors American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute VSee Health Natera American Oncology Network (NASDAQ:AONC) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk. Is AONC or ACONW more profitable? Company Net Margins Return on Equity Return on Assets American Oncology NetworkN/A N/A N/A Aclarion N/A N/A N/A Does the media prefer AONC or ACONW? In the previous week, American Oncology Network had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for American Oncology Network and 0 mentions for Aclarion. American Oncology Network's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score. Company Overall Sentiment American Oncology Network Neutral Aclarion Neutral Which has preferable earnings and valuation, AONC or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmerican Oncology Network$1.34BN/AN/AN/AN/AAclarion$54.60KN/AN/AN/AN/A SummaryAmerican Oncology Network beats Aclarion on 2 of the 2 factors compared between the two stocks. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$225.22M$5.55B$9.55BDividend YieldN/A5.90%4.73%4.14%P/E RatioN/A383.8429.0924.51Price / SalesN/A221.70374.9979.89Price / CashN/A47.1424.4827.20Price / BookN/A5.108.675.84Net IncomeN/A-$15.55M$3.24B$264.99M7 Day PerformanceN/A2.47%0.13%-0.57%1 Month PerformanceN/A7.06%7.85%6.32%1 Year PerformanceN/A10.91%29.74%24.00% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.03-7.1%N/A-32.6%$0.00$54.60K0.007Positive NewsGap DownAONCAmerican Oncology NetworkN/A$9.75-2.5%N/A+202.6%$0.00$1.34B0.001,520News CoverageGap DownDHACWDigital Health AcquisitionN/A$0.06-5.8%N/A-61.8%$0.00N/A0.00N/AGap UpFMSFresenius Medical Care AG & Co. KGaA3.5414 of 5 stars$25.79-1.4%$27.80+7.8%+30.8%$0.00$20.63B23.031,384Positive NewsEarnings ReportGap UpHigh Trading VolumeLFMDPLifeMDN/A$24.05-0.8%N/A+10.2%$0.00$234.01M0.00230News CoverageOTRKPOntrakN/A$0.230.0%N/A-88.9%$0.00$10.84M0.00250Upcoming EarningsGap DownHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01+8.0%N/A-73.2%$0.00$1.49B0.00500Positive NewsHigh Trading VolumeTALKWTalkspaceN/A$0.08+3.8%N/A-17.8%$0.00$194.36M0.00500Positive NewsTOIIWOncology InstituteN/A$0.12-4.5%N/A+479.9%$0.00$403.15M0.00660Positive NewsGap DownVSEEVSee Health1.3683 of 5 stars$1.32-1.5%$5.00+278.8%-67.3%$0.00N/A0.00N/APositive NewsHigh Trading VolumeNTRANatera3.5941 of 5 stars$140.96+3.8%$183.76+30.4%+37.1%$18.55B$1.70B-95.894,434Upcoming Earnings Related Companies and Tools Related Companies AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives VSEE Alternatives NTRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACONW) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWall Street Hates This Gold IRA Strategy—Here’s WhyWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredWashington Thinks They Own Your Bank AccountWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
